Print Page

Medicine recalls

 
Canada: Recall: SENNA Tablet USP; JAMP Senna; Jamp - SENNA: total counts of yeasts and molds are out of specification
 
Health Canada announces that Jamp Pharma Corporation is recalling one lot of SENNA Tablet USP ; JAMP Senna Tablet; Jamp - SENNA Tablet (sennoside A&B 8.6 mg) (lot number: 2A02B3015) from retailers because the combined total counts of yeasts and molds are out of specification in affected lots.

The products are used as stimulant laxative to promote bowel movement and short-term relief of occasional constipation.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/senna-tablet-usp-jamp-senna-jamp-senna-total-counts-yeasts-and-molds-are-out

In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 20 May 2022.

Ends/Thursday, Feb 6, 2025
Issued at HKT 15:15
 
Related Information:
Canada: Recall: JAMP-SENNA Tablet 8.6mg: Out of Specification Posted 2022-05-20
 
back